| Literature DB >> 34007608 |
B DeeAnn Dugan1, Peter J Hughes1, Sarah Wright1.
Abstract
OBJECTIVE: To evaluate the effectiveness of a Continuing Professional Development (CPD) plan template used in Fall of 2017 on quality of SMART goal development and student quiz scores. INNOVATION: The gap in time from when pharmacology is taught and when it is applied has contributed to poor student retention and performance in the diabetes pharmacotherapy course. To address this gap, the diabetes pharmacotherapy learning sequence was redesigned and included a self-assessment (pre-test), and the completion of a "CPD plan template", which involved writing 1-3 SMART goals for each question missed on the pre-test. Following sequence completion, students took an identical post-quiz. Pre- and post-quiz scores were compared. Quality of CPD plan SMART goals was evaluated. KEYEntities:
Keywords: Continuing Professional Development; Diabetes; Pharmacotherapy; SMART goals
Year: 2020 PMID: 34007608 PMCID: PMC8051917 DOI: 10.24926/iip.v11i2.1990
Source DB: PubMed Journal: Innov Pharm ISSN: 2155-0417
Pre/Post-Quiz Statistics and Correlated Learning Objectives
Compare and contrast, both within and between classes, the different oral and injectable agents used in the treatment of diabetes. | 11 | 47 | 0.5 | 0.21 | 76 | 0.03 | 0.02 | R |
52 | 0.38 | 0.12 | 50 | 0.41 | 0.30 | |||
17 | 0.44 | 0.29 | 63 | 0.25 | 0.19 | |||
32 | 0.38 | 0.13 | 48 | 0.59 | 0.42 | |||
18 | 0.09 | 0.00 | 55 | 0.44 | 0.30 | |||
30 | 0.16 | 0.02 | 69 | 0.25 | 0.25 | |||
37 | 0.56 | 0.27 | 64 | 0.28 | 0.24 | |||
49 | 0.69 | 0.34 | 52 | 0.41 | 0.21 | |||
11 | 0.16 | 0.10 | 71 | 0.16 | 0.1 | |||
37 | 0.22 | 0.09 | 50 | 0.59 | 0.42 | |||
34 | 0.38 | 0.13 | 74 | 0.19 | 0.22 | |||
Compare and contrast the different insulins regarding onset, peak, duration, OTC status, and use in patients with diabetes. | 2 | 72 | 0.22 | 0.02 | 60 | 0.31 | 0.13 | R |
55 | 0.81 | 0.35 | 69 | 0.25 | 0.27 | |||
Design initial insulin regimens in type 1 and type 2 diabetes patients. | 3 | 18 | 0.31 | 0.23 | 49 | 0.59 | 0.44 | N |
23 | 0.34 | 0.14 | 56 | 0.43 | 0.33 | |||
80 | 0.38 | 0.28 | 61 | 0.41 | 0.34 | |||
Individualize A1C goals, as appropriate, based on individual patient factors. | 1 | 15 | 0.25 | 0.15 | 71 | 0.16 | 0.17 | N |
Appropriately adjust insulin regimens in type 1 and type 2 diabetes patients. | 1 | 22 | 0.22 | 0.07 | 71 | 0.22 | 0.23 | N |
List and appropriately apply the screening, clinical presentation, and diagnostic criteria for diabetes. | 1 | 20 | 0.38 | 0.24 | 67 | 0.25 | 0.22 | N |
Adjust and optimize a treatment plan for a patient with type 2 diabetes. | 2 | 19 | 0.19 | 0.07 | 41 | 0.43 | 0.32 | N |
11 | 0.06 | 0.00 | 51 | 0.41 | 0.34 | |||
List the major results of the ACCORD, ADVANCE, VADT, and UKPDS Follow Up, and DPP. | 1 | 25 | 0.19 | 0.01 | 74 | 0.13 | 0.11 | N |
Figure 1.CPD Plan Template